Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...

The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. | The announcement follows a five-year, $50-billion ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands ...

The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

INDIANAPOLIS (WISH) — Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana.

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

More: Roche pours $50 billion into U.S. manufacturing; at least one new plant will be in Indiana Roche Diagnostics solidified its North American headquarters in Indianapolis in 1998 and has maintained ...

Swiss pharmaceutical giant Roche announced today that it plans to invest 2.04 billion yuan (about $283M) in building a new ...